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Racial health disparities have been shown in Cardiovascular Disease (CVD) with African 
Americans having a substantially greater risk compared to Caucasian Americans. One potential 
factor explaining racial differences in CVD may be increased levels of systemic inflammation in 
African Americans compared to Caucasians. Epidemiological studies have shown that CRP (a 
marker of systemic inflammation) is an independent risk factor for cardiovascular mortality6,7, 
and is higher in African Americans compared to Caucasians. In addition to the elevated CRP 
levels, African Americans have increased levels of obesity and lower cardiorespiratory fitness 
compared to Caucasians. Although results have been inconsistent in studies related to exercise 
interventions to improve CRP levels, many studies have had primarily Caucasian participants 
and/or have used different intensities of aerobic training. 
PURPOSE: The purpose of the present study was to determine the effects of moderate and high 
intensity aerobic exercise training on CRP in obese African-American men and women.  
METHODS: The present study was a randomized-controlled trial of 60 obese and overweight 
African American men and women (body mass index of 25–45 kg/m2), 35-65 years. Participants 
were randomized to the moderate intensity (MOD-INT; n = 20), high intensity (HIGH-INT; n = 
20), or non-exercise control group (n = 20) for a 24-week intervention. The moderate intensity 
group participated in aerobic exercise at 50% of their VO2 max, and the high intensity group 
participated in aerobic exercise at 75% of their VO2 max. Participants completed a 12-hour 
fasted blood draw at the East Carolina Heart Institute. A venous blood sample of a total of 21 mL 
of blood was drawn by the study nurse pre and post exercise intervention. Blood samples were 
sent to a clinical laboratory (LabCorp Inc., Burlington, NC) for a complete analysis of metabolic, 
lipid, insulin level measures, CRP, and blood chemistries. The serum separator tube was sent to 
LabCorp for measurement of C-reactive protein.   
RESULTS: There were 11 participants in the control group, 10 participants in the moderate 
intensity exercise group, and 13 in the high intensity exercise group. There were no significant 
differences between the randomization groups for age, gender, weight, BMI, waist circumference, 
body fat percentage, glucose, insulin, and CRP (p> 0.05). We did not observe significant change 
in CRP levels among study groups in the MOD or the HIT group compared to the CON in obese 
African-American adults (p=1.00). The association between exercisers and change in CRP and fat-
mass approached a significant change (r=-0.379, p=0.07). The HIGH-INT group had a larger 
increase in VO2 max (ml•kg•min; L/min) (p<0.05) compared to the CON group.  Also, there was 
a significant relationship between the CON group and MOD intensity group in estimated METs 
(p<0.01). Data for changes in clinical risk factors between participants based on change in CRP 
are shown in Table 2. There were no significant changes found in CRP for any clinical risk factors 
between non-responders and responders (p>0.05).  
CONCLUSION: In conclusion, we observed that neither moderate or high intensity aerobic 
decreased systemic inflammation levels in obese African Americans. Secondly, CRP was not 
improved with a change in fat-mass in exercisers. Future research could allow for the analysis of 
both Caucasian and African Americans, allowing for a more direct comparison between the two 
races for the intervention variables measured. Also, it could entail an interval training aerobic 
group, as well as a resistance training exercise group to elucidate further comparisons in 
intervention variables. Lastly, future studies may want to combine dietary and exercise to 





























































A Thesis Presented to 
The Faculty of the Department of Kinesiology 
East Carolina University 
 
 
In Partial Fulfillment of the Requirements for 






















































































DIRECTOR OF THESIS: ____________________________________ 





COMMITTEE MEMBER: __________________________________ 





COMMITTEE MEMBER: __________________________________ 





CHAIR OF THE DEPARTMENT OF KINESIOLOGY: ___________________________ 





DEAN OF THE GRADUATE SCHOOL: ________________________________ 










Table of Contents 
List of Tables……………………………………………………………………………………..vi 
List of Figures…………………………………………………………………………………...vii 
Chapter I: Introduction ................................................................................................................. 1 
Purpose ..................................................................................................................................................... 3 
Hypothesis ................................................................................................................................................ 3 
Delimitations ............................................................................................................................................ 3 
Limitations ............................................................................................................................................... 3 
Operational Definitions ........................................................................................................................... 3 
Chapter II: Review of Literature ................................................................................................... 4 
CRP and CVD risk .................................................................................................................................. 5 
CRP in African Americans (Racial Differences) .................................................................................. 7 
Exercise Training and CRP .................................................................................................................. 12 
Summary ................................................................................................................................................ 15 
Chapter III: Methods ................................................................................................................... 17 
Participants………………………………………………………………………………………...….17 
Participant Screening…………………………………………………………………………………17 
Participant Assessment: Baseline and Follow Up…………………………………………………...18 
Blood Draw: Pre and Post Intervention……………………………………………………………..18 
Exercise Intervention………………………………………………………………………………….19 
Statistical Analysis……………………………………………………………………………………….20 
Chapter IV: Results ...................................................................................................................... 21 
Chapter V: Discussion ................................................................................................................. 22 
Bibliography ................................................................................................................................. 33 




List of Tables  
1. Baseline Participant Characteristics…………………………………………………..….25 
2. Change in Intervention Statistics………………………………………….……………..26 




List of Figures 
1. Change in CRP Across Intervention Groups…………………………………………….28 
2. Change in CRP vs. Change in Weight…………………………………………………...29 
3. Change in CRP vs. Change in Fat-Mass…………………………………………………30 
4. Change in CRP vs. Change in Insulin…………………………………………………....31 
5. Change in CRP vs. Change in Glucose…………………………………………………..32 
 
 
Chapter I: Introduction 
 
 
 The leading cause of mortality in both men and women in the United States is 
cardiovascular disease (CVD)1,2. Elevated systemic inflammation plays a central role in the 
pathophysiology of CVD, which represents a proinflammatory state3. CRP, a protein synthesized 
in the liver, increases in response to excess chronic inflammation4. Previous research shows 
elevated CRP levels are a predictive marker of inflammation and a key factor in the development 
of CVD4,5. Epidemiological research suggests high levels of CRP is an independent risk factor 
for both cardiovascular events and cardiovascular disease mortality6,7. Specifically, recent data 
indicates that every increase in 1.10 mg/L of CRP is associated with a 2- fold increase in CVD 
mortality8. Thus, CRP is a biomarker predictive of CVD6–8.  
Of note, African Americans have a higher rate of CVD risk factors compared to 
Caucasians. This difference in CVD risk factors between races may be attributed to higher levels 
of obesity amongst African Americans9. In addition to the increased prevalence of obesity in 
African Americans, previous literature demonstrates higher CRP levels in African American 
subjects, which may impose an increased risk for future CVD events10,11. It has been concluded 
that significant race differences exist in the population distribution of CRP10. Thus, interventions 
that reduce CRP in African Americans may have a favorable impact on cardiovascular disease 
risk and health disparities.  
While CRP has been shown to be a risk factor for CVD, previous research has also 
discovered that higher levels of CRP are closely associated with the presence of obesity10. The 
accumulation of an excessive amount of fat is associated with the release of pro-inflammatory 
cytokines and subsequently increased CRP levels12. Cross-sectional studies have  suggested that 
elevated CRP levels are more prevalent in obese individuals compared to non-obese13–15. 
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According to a study conducted through The National Health and Nutrition Examination Survey, 
obese women were 4.8 times more likely to have clinically elevated CRP levels of >1 mg/L 
compared to normal-weight women, and obese men were 6.2 times more likely to have elevated 
CRP levels compared to normal-weight men13. Obesity continues to be a key factor in CVD, and 
a potential factor in elevated CRP levels.  
Exercise training has been recommended by the American Heart Association (AHA) and 
the American College of Sports Medicine to reduce cardiovascular disease and has been shown 
to be an effective strategy to reduce systemic inflammation. According to the AHA, decreased 
physical activity is the fourth risk factor for atherosclerotic heart disease16. Recent data has 
shown that low cardiorespiratory fitness is associated with higher levels of CRP and 
cardiovascular mortality17,24. While research has shown fitness levels are inversely associated 
with cardiovascular mortality, studies investigating the effect of exercise intervention on CRP 
levels have mixed results. Although many studies conclude that a variety of aerobic training does 
improve CRP concentration levels, there is a gap of research supporting the effect of specific 
exercise intensity in CRP concentrations. Vigorous intensity exercise increases aerobic fitness 
more effectively than moderate intensity exercise, therefore, it is logical to investigate the 
efficacy of varying aerobic exercise intensities on subsequent changes in CRP levels 20.  
Obese individuals with low cardiorespiratory fitness are more likely to have higher CRP 
level, as well as a higher risk for CVD. A lifestyle modification such as an increase in exercise is 
associated with improved CRP levels. However, little data exists directly comparing moderate to 
high intensity exercise training on CRP levels in obese adults and no studies exist, to our 
knowledge, in African Americans. Thus, a study comparing aerobic exercise training intensity on 
CRP in obese African Americans will provide valuable knowledge to the field. may add more 
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input on how to lower CRP levels due to the potential decrease in fat loss from aerobic exercise 
training.  
Purpose 
 The purpose of this study is to determine the effects of moderate and high intensity 
aerobic exercise training on CRP in obese African American men and women.  
Hypothesis 
 The levels of CRP in obese African American will decrease with high intensity aerobic 
exercise training compared to moderate intensity exercise training.  
Delimitations  
 The present study includes the demographic of sedentary, obese African American aged 
35-65 years, and moderate and high intensity aerobic exercise training on a treadmill.  
Limitations  
The use of sedentary, obese, African Americans, aged 35-60 years limits the 
generalizability of results to other ethnicities, age groups, and BMI classifications. Results 
cannot be inferred regarding other intensities of exercise due to the exercise intervention 
consisting of a moderate and vigorous intensity. The use of a treadmill also limits 
generalizability to other exercise training modalities.   
Operational Definitions  
1. CVD: Cardiovascular disease  
2. CRP: C-reactive protein  
3. CRF: Cardiorespiratory fitness 





Chapter II: Review of Literature 
 
In the United States, cardiovascular disease (CVD) is the leading cause of mortality in 
both men and women1,2. Underlying the pathophysiology of cardiovascular disease is elevated 
systemic inflammation, which represents the presence of a systemic proinflammatory state 3. It is 
believed inflammation is triggered by excess low-density lipoprotein (LDL) cholesterol, 
lipocytes, and other cellular toxins within the blood stream21,22. LDL cholesterol proceeds to 
collect in the damaged area of the arterial wall, causing fatty streaks21. A chemical reaction 
causes oxidization of the LDL fatty streaks, signaling white blood cells known as monocytes to 
travel to the damaged site21. The monocyte converts into a macrophage, attempting to digest the 
cholesterol molecules21.  Foam cells, macrophages with large amounts of oxidized lipids,  begin 
to accumulate, forming plaque within the blood vessels and inhibiting blood flow21. The arterial 
wall thickens as plaque accumulates, driving the formation of atherosclerosis21. Furthermore, the 
accumulation of fibrous plaque formation augments an individual’s susceptibility for a 
myocardial infarction21,22. The progression of atherosclerotic plaque is associated with increased 
production of proinflammatory cytokines22. Cytokines, a group of proteins secreted by cells of 
the immune system, act as chemical messengers to regulate natural defense mechanisms to 
symptoms such as inflammation22,23. During elevated systemic inflammation, a protein produced 
in the liver called C-reactive protein (CRP) will increase in response to excess inflammation4. 
Furthermore, studies have shown that the elevated concentration of CRP is a predictive marker 
of inflammation which underlies the development of CVD4,5.  
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CRP and CVD risk  
A protein synthesized in the liver called C-reactive protein (CRP) will increase in 
response to excess inflammation4. Previous research has shown that elevated levels of  CRP is a 
predictive marker of inflammation4,5. Research supports this potential marker of vascular 
inflammation as a key pathogenic factor in the development of atherosclerosis, increasing the 
risk for CVD6,7. According to the AHA24, those with CRP levels >3mg/L are categorized at a 
high risk for CVD. Much of the epidemiological research suggests that high levels of CRP is an 
independent risk factor for not only cardiovascular events, but mortality6,7.  
One study by Bahadursingh et al.6 evaluated hospital patients (N=300) of Cross Crossing 
Medical Centre emergency department receiving routine cardiovascular assessment. Cases were 
divided into two groups. One group of patients with a cardiovascular event and the second group 
of patients were controls, those without a cardiovascular event6. Thirty-three percent of 89 
subjects with CVD had higher CRP levels (>0.8 mg/L)6. The risk of CVD associated with an 
elevated CRP (> 0.8 mg/L) was generated through the calculation of odds ratios6. The results of 
this study indicated that a patient with high CRP levels had 1.8 times greater risk of CVD 
compared to a patient with normal CRP levels (>0.8 mg/L)6. Thus, this study concluded that 
there is an association between increased CRP levels and a high risk for CVD 6.  
To further support the association between CRP and CVD, Cozlea et al.7 evaluated the 
relationship between CRP levels and global CVD risk in patients (N=100) with cardiovascular 
risk factors in high risk regions of Europe7. The authors assessed the risk of CVD in each subject 
utilizing the systematic coronary risk evaluation (SCORE) chart, which estimates the risk of a 
fatal atherosclerotic events occurring in the next 10 years (low risk <1%, moderate risk 1-4%, 
high risk 5-9%, and very high risk 10%)7. The SCORE diagram assesed differet parameters 
 6 
such as gender, age, smoker/non-smoker status, plasma cholesterol levels, and systlic blood 
pressure values7.  Normal values for CRP in this study was classified as <10 mg/L7. All patients 
(n=100) in the study, both men and women, were categorized into two groups based on the 
measured CRP levels7.  Patients were divided into two groups: Group A patients (n=50) with 
CRP levels <10 mg/L, and group B patients (n=50) with CRP levels of 10 mg/L7. Following the 
comparison of the SCORE values, 90% of the patients in Group A (<10 mg/L) were low to 
moderate risk for CVD, while 80% Group B (10 mg/L) were high to very high risk for CVD10. 
The CRP levels of Group B significantly correlated to a high risk of CVD following a 2x2 Chi 
square test (p=0.0001) 7  Given the results, the authors concluded that a CRP level over 10 mg/L 
is correlated with an over 4% risk of developing a fatal CVD in the next 10 years7. The 
incorperation of CRP in the CVD risk stratification can allow for the improvement of risk 
statification7. The inclusion of CRP in CVD screen may improve the accuracy of screening for 
CVD. 
Building on this, Jeppesen et al.8 investigated the relationship between CRP and CVD via 
analysis of  2,357 Danish men and women from the general population. The age of subjects 
ranged from 41-72 years, and all were without major symptoms of CVD at baseline8. The study 
had a median follow up of 9.4 years and found that CRP was an independent predictor of CVD 
as 1.33 (CI: 1.14-1.55) (P<0.001) in the fully adjusted model (e.g.risk factors unrelated to 
metabolic syndrome – age, sex, smoking habit and total cholestoral value)8. Per every increase in 
1.10 mg/L of CRP was associated with a 95% increase in CVD8.  The primary finding of this 
study was that the level of CRP was a significant risk factor in the development of future CVD8.  
Based on the current data, several research studies indentified that CRP is an independent 
risk factor of CVD6–8. The integration of CRP into the risk stratifications for CVD may prove to 
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be valuable in order to improve the effectiveness of risk classifications for CVD10. While CRP 
has been named to be an independent risk factor for CVD, previous research has also discovered 
that higher levels of CRP are closely associated with the presence of obesity10.  
 
CRP in African Americans (Racial Differences)  
It is reported that African American’s have a higher risk of CVD compared to 
Caucasians. This may be due, in part, to higher levels of obesity amongst African Americans9. 
Nearly 30% of Caucasian Americans adults are considered obese, in comparison to 45% of 
African American adults25. Additionally, the prevalence of obesity is 66% percent in African 
American females, compared to Caucasian American females at 47%25. However, there is a lack 
of research comparing CRP levels between African American and Caucasian Americans. Khera 
et al.10 conducted a study to determine whether there are race and gender differences in CRP 
levels. CRP was measured in 2,749 Caucasian and African American subjects participating in the 
Dallas Heart Study, ages 30-6510. African American participants had higher CRP levels 
compared to white subjects (median, 3.3 vs. 1.8 mg/L; p < 0.001)10. Following an adjustment for 
cardiovascular risk factors, estrogen and statin use, and BMI, a CRP level >3 mg/L was  more 
prevalent in Caucasian women (OR 1.6; 95% CI, 1.1 to 2.5) and African American women (OR 
1.7; 95% CI, 1.2 to 2.6) but not in African American men (OR 1.3; 95% CI, 0.8 to 1.9)10 when 
compared with Caucasian males. The authors concluded that significant race and gender 
differences exist in the population distribution of CRP10.  
 An additional study, the Study of Women’s Health Across the Nation (SWAN), 
conducted a multiethnic cross-sectional analysis in 3,154 women, without any known CVD11. 
The study population was 47.4% white, 27.7% African American, 8.5% Hispanic, 7.7% Chinese, 
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and 8.6% Japanese. Hedgepeth et al.11 observed that African American women had the highest 
median CRP levels (3.2 mg/L), followed by Hispanic women (2.3 mg/L). The African American 
ethnicity was associated with CRP concentrations >3 mg/L, typically associated with high risk of 
CVD, following adjustment for age, socioeconomic status, BMI, and other risk factors (OR 1.37; 
95% CI, 1.07-1.75) 11. CRP concentrations varied among ethnic groups, with the highest levels 
among African American women11. Several interpretations from the studies above can be made; 
however, it is clear that higher CRP levels in African American subjects may impose an 
increased risk for future CVD events10,11. African American subjects indeed have a greater 
prevalence of cardiovascular risk factors, and higher CRP levels seem to be linked to this 
risk10,11. Since research in the area of racial differences in CVD risk factors is newly emerging, 
further research is needed to focus within the African American race to confirm the high 
prevalence of CRP levels as a main CVD risk factor,11. The racial differences in inflammation 
levels may directly contribute to the association of higher CVD mortality in African American 
subjects10. 
 
Obesity and Systemic Inflammation  
  The increased prevalence of obesity, an atherosclerotic CVD risk factor, has become a 
worldwide epidemic 26. Currently, more than 50% of US adults are overweight, while 20% of 
adults are obese17. Another study focusing on the prevalence of obesity in the United States 
concluded that obesity was more prevalent in 32.2% among adult men and 35.5% among adult 
women27. Obesity is defined as having a body mass index (BMI) 30 kg•m2 or waist girth >102 
cm (40 in) for men and >88 cm (35 in) for women28. It is the accumulation of an excessive 
amount of fat that potentially interferes with the preservation of optimum health12. The excess 
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lipids within the adipose tissues release inflammatory mediators, such as cytokines tumor 
necrosis factor  and interleukin 6 (IL-6)12. The accumulation of  cytokines and subsequent 
inflammation stimulates the body to synthesize CRP12.  
Previous studies have concluded that high CRP levels are more prevalent in obese 
individuals compared to non-obese13–15. A clinical trial that evaluated CRP levels within obese 
young adults, aged 17-39 years, found higher BMI associated with higher CRP concentrations 
compared to young adults with normal BMI13.  For example, Visser et al.13 followed 16,616 men 
and nonpregnant women over the age of 17 in the National Health and Nutrition Examination 
Survey13. Following the study, obese women were 4.8 times more likely to have clinically 
elevated CRP levels of >1 mg/L compared to normal-weight women, and obese men were 6.2 
times more likely to have elevated CRP levels compared to normal-weight men13. Also, waist-to-
hip ratio was positively associated with elevated CRP levels for both men and women13. For 1-
SD increase in waist-to-hip ratio, men were 1.41 times and women were 1.21 times more prone 
to have elevated CRP levels13.  
Furthermore, Santos et al.15 evaluated the association between CRP levels and metabolic 
syndromes in 957 subjects, ages 18-92 years15. Questionnaires were presented assessing social, 
demographic, behavioral, and clinical measures15. Anthropometrics and fasting blood samples 
were also collected15. Subjects were excluded if CRP levels measured 10 mg/L due to the 
potential indication of other clinically relevant inflammatory conditions15. Results showed higher 
adjusted mean levels of CRP (2.34 mg/L vs 1.36 mg/L,  P < 0.001) in adults with metabolic 
syndrome compared to those without metabolic syndrome15. An increase in metabolic syndrome 
features was associated with an increase in mean CRP levels (0.97 to 3.18 mg/L)15. A higher 
prevalence for metabolic syndrome and high levels of CRP were present in older subjects, 
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former alcohol drinkers, and sedentary indivduals15. Additionally, significantly higher mean CRP 
levels were found in subjects with central obesity (2.45 mg/L vs. 1.24 mg/L, P<0.001), 
hypertriglyceridemia (2.17 vs 1.32 mg/L, P<0.001), high fasting glucose (1.96 vs 1.112 mg/L, 
P<0.001), and high blood pressure (1.76 mg/L vs. 1.12 P<0.001) compared to non-obese 
individuals15. Although there are numerous reasons for high levels of CRP, studies suggest it 
corresponds strongly with central obesity due to the excess inflammation13,15. A prominent theme 
contributing to obesity amongst individuals is the abundance of visceral adipose tissue. 
Previous research suggests the visceral fat depot is a stronger contributor to CRP levels in 
individuals compared to other parameters of obesity13,29,30. Excess visceral adiposity potentially 
results in a proinflammatory condition, therefore, resulting in a low grade systemic 
inflammation, which further augmenting individual risk for CVD31.  Faber et al.30 hypothesized 
that visceral adipose tissue contributes to systemic inflammation of CRP. In 2,410 patients with 
vascular diseases, visceral and subcutaneous adipose tissue were analyzed through 
ultrasonography30. The association between fat measurements and CRP levels were measured 
using linear regression anaylsis30. For one-standard deviation increase of visceral fat, CRP levels 
increased by 0.10 mg/L (0.07-0.12) in men and 0.11 mg/L (0.15-0.19) in women30. Faber et al.30 
found visceral fat thickness to be the strongest contributor of systemic CRP levels in patients 
with vascular diseases. Since IL-6 is a key stimulator in the production of acute phase proteins, 
such as CRP, and visceral adipose releases more IL-6 compared to subcutaneous adipose 
tissue,12,13 this may explain the observed trend of the relationship between high BMI and CRP in 
obese individuals13.  
 
Fitness and CRP  
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The improvement of exercise endurance and cardiorespiratory fitness has been an 
important focus to reduce CVD events16. In fact, the American Heart Association ranks 
decreased physical activity as the fourth risk factor for atherosclerotic heart disease16. Research 
concludes that cardiorespiratory fitness level is inversely associated with cardiovascular 
mortality and levels of CRP17,24.  
Aronson et al.17 conducted a cross-sectional study in which levels of CRP were lower 
with increasing levels of cardiorespiratory fitness. Subjects (n=1,640) with metabolic syndrome 
were assessed for cardiovascular risk factors at the Rambam Center for Preventative Medicine17. 
The authors found for every one-unit increase in metabolic equivalents (METs), the adjusted 
geometric mean value of CRP decreased by 0.058 mg/L (95% confidence interval [CI] 0.038 to 
0.078)17. The adjusted geometric mean CRP value in subjects who were in the upper fitness 
quartile compared with subjects in the lower fitness quartile was 1.48 versus 0.93 mg/L in 
subjects without metabolic syndrome (p= 0.01)17.  Results indicated that subjects with metabolic 
syndrome who maintain a high fitness level have lower CRP concentrations compared to those 
with a low fitness level17. The results of the study indicate that something related to the 
physiological adaptations of being more fit appears to regulate CRP concentrations independent 
of other components of metabolic syndrome and other influencers of CRP levels17.  
Aronson et al.32 conducted an additional study investigating the association between 
physical fitness and CRP. In a cross-sectional study, physical fitness was assessed in 892 adults 
based on fitness levels determined by the Bruce protocol maximal treadmill test32. After 
adjustment for age, gender, body mass index, smoking habit, presence of diabetes and 
hypertension, CRP levels decreased with increasing quartiles of fitness (p for trend <0.0001)32. 
Subjects in the highest fitness quintile had significantly lower adjusted odds of having high (>3 
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mg/L) CRP levels (odds ratio 0.53; 95% CI 0.39-0.71) compared to those in the lowest fitness 
quintile32. Aronson et. al32 concluded that CRP concentration levels decrease consistently with 
increasing levels of cardiorespiratory fitness.  
The Aerobics Center Longitudinal Study was an epidemiological study in which the 
association between cardiorespiratory fitness and CRP were examined. Church et al.19 assessed 
722 non-Hispanic, white males in the Cooper Clinic in Dallas, TX19.  The geometric mean CRP 
levels and an odds ratio of elevated CRP across 5 levels of cardiorespiratory fitness was 
assessed19. Following full adjustment of the geometric mean across fitness quintiles, 49% of the 
men in the lowest fitness quintile have higher CRP value compared to 16% of the men in the 
highest fitness quintile19. There is a significant relationship for prevalence of high CRP values 
across the fitness quintiles (p<0.001)19. Patients with the highest fitness quintile (odds ratio of 
0.17, 95% confidence interval 0.08 to 0.37) have the lowest risk of  high CRP value compared to 
those in the lowest fitness quintile19. From these results, Church et al.19 concluded that 
cardiorespiratory fitness levels were inversely associated with CRP levels. Furthermore, CRP 
values were significantly greater in the lowest fitness categories compared with higher fitness 
categories within overweight and obese individuals19. Low cardiorespiratory fitness has been 
proposed as a significant CVD risk factor that could be improved through a focus in lifestyle 
intervention, thus improving risk stratification18. These findings suggest that an assessment of 
cardiorespiratory fitness may improve the accuracy of risk prediction18. Furthermore, it supports 
another health benefit of fitness18.  
 
Exercise Training and CRP 
Recent studies have examined the effects of obesity and high levels of CRP in lifestyle 
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interventions, such as an increase in physical activity and exercise training to decrease the risk of 
atherosclerotic CVD33,34. Stewart et al.35 examined the effects of an exercise training program on 
CRP in postmenopausal women. Subjects (N=464) consisted of sedentary, overweight/obese, 
postmenopausal women with elevated systolic blood pressure (120.0 to 159.9 mm Hg)35. The 
subjects were randomized into 1 of 4 groups: a non-exercise control or 1 of 3 aerobic exercise 
groups; the aerobic exercise groups had an exercise energy expenditure of 4, 8, or 12 
kcal/kg/week (KKW), respectively, for 6 months at training intensity of 50% of VO2 peak35. Of 
the 464 participants, 427 returned for follow-up testing (92.0%)35. Results showed there were no 
differences in median CRP change between any of the groups (p=0.6)35. However, there was a 
decrease in CRP levels across quartiles of change in weight35. The mean CRP change, adjusted 
for baseline CRP and group randomization, was significantly (p<0.02 for each) different in the 
4th quartile (most weight loss) compared to the 1st, 2nd, and 3rd quartiles of weight35. The 4th 
quartile mean weight loss was 5.9 (3.0) kg and the mean change in CRP was 1.0 (2.8) mg/L35. 
Although it seems that 6-months of exercise training at 4, 8, or 12 kcal/kg/week did not improve 
CRP in previously sedentary, overweight and obese, postmenopausal women, participants that 
experienced reduced weight had a decreased CRP level (0.15 mg/L; p<0.001)35. In conclusion, 
aerobic training exercise in postmenopausal sedentary women was associated with decreased 
CRP levels if there was a reduction in weight35.  
Supporting that CRP could potentially change with weight loss due to exercise training is 
the Inflammation and Exercise (INFLAME) study conducted by Church et al36. The purpose of 
the study was to examine whether aerobic exercise without dietary intervention can reduce CRP 
in individuals with elevated CRP36. The study randomized sedentary men and women (N=162) 
with elevated CRP ( 2.0 mg/L) into a non-exercise group or an exercise group that trained for 4 
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months at moderate- to vigorous activity (60-80% VO2max)36. Results indicated there was no 
differences in median change in CRP between the control and exercise groups (0.0[-0.5, 0.9] 
verses [-0.8, 0.7] mg/L, p=0.4)36. However, similar to Stewart et al.35 change in weight was 
correlated with change in CRP36. For both weight loss and body fat loss, the exercise group 
tertile with the largest reduction in these variables had significant reductions in CRP compared to 
all groups with less weight and body fat loss (P < 0.05)36. Church et al.36 concluded that exercise 
without weight loss is not associated with a reduction in CRP. When these results were further 
analyzed, the changes in the weight and fat in the exercise group were associated with the 
changes in CRP, proposing that exercise-induced reductions in CRP are primarily due to 
reductions in weight and body fat36.  
Furthermore, studies prescribing a higher exercise intensity show greater effects than a 
low or moderate exercise intensity33,34. Goldhammer et al.33 found that aerobic training may 
lower the risk for coronary artery disease (CAD) by modifying inflammation levels. Throughout 
a 12-week aerobic exercise training program at 70-80% of individual maximum heart rate, 28 
male and female patients ages 64 and older underwent 45 minute sessions of continuous aerobic 
exercise for 3 days a week33. Plasma CRP levels were examined in response to the exercise 
training, and indicated a reduction in CRP levels by 48% from 7.54.2 to 3.93.5 mg/L 
(p<0.001) independent of changes in body weight or BMI33. The relationship of physical activity 
with lower levels of inflammation and CRP may provide another cardioprotective mechanism33.  
Similarly, Akbarpour et al.34 conducted a study to investigate the effect of 12 weeks of 
aerobic training on inflammatory markers of CVD in obese men. Subjects (n=16) were non-
athlete, obese men assigned to an experimental group or a control group34. The experimental 
group underwent 3 aerobic training sessions per week at 75-85% of the maximum heart rate for 
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12 weeks, while the control group did not participate in aerobic training34. The investigators 
discovered that aerobic training significantly decreased CRP levels (p=0.002) in the experimental 
group 34. The conclusion was drawn that regular aerobic training does decrease the risk of CVD 
by reducing the levels of CRP34.  
Contrary to the studies above, Huffman et al.37 sought to determine if modulating fitness 
with exercise training produced changes in CRP in a population at risk for cardiovascular 
disease. Huffman et al.37 enrolled 193 overweight men and women to a 6-month intervention of 
low amount-moderate intensity, low amount-high intensity, or high amount-high intensity 
aerobic training or no physical activity. Although the intervention showed significant 
improvements in fitness, visceral adiposity, and subcutaneous adiposity, and insulin sensitivity, 
the 6 months of aerobic training did not significantly affect CRP (p> .20)37. 
As previously stated, there are conflicting results regarding the interaction between 
exercise training and CRP. Through further examination of these studies, decreased CRP is 
associated with exercise greater than low intensity. Therefore, it can be concluded that moderate 
to high intensity aerobic training decreases CRP levels and thus systemic inflammation33,34. 
While previous research emphasizes that various intensities of aerobic training do improve CRP 
concentration levels, however, there is a gap of knowledge supporting the effect of specific 
exercise intensity on CRP concentrations. Research has shown that low cardiorespiratory fitness 
is associated with high CRP levels17,24, and high intensity exercise is more effective at improving 
cardiorespiratory fitness. Therefore, it is plausible that high intensity exercise could be more 
beneficial at improving CRP levels33,34. 
Summary 
Racial health disparities have been shown in CVD with African Americans having a 
 16 
substantially greater risk compared to Caucasian Americans. One potential factor explaining 
racial differences in CVD may be increased levels of systemic inflammation in African 
Americans compared to Caucasians. Epidemiological studies have shown that CRP (a marker of 
systemic inflammation) is an independent risk factor for cardiovascular mortality6,7, which is 
higher in African Americans compared to Caucasians. Additionally, African Americans have 
increased levels of obesity and lower cardiorespiratory fitness, and elevated CRP levels 
compared to Caucasians. Although results have been inconsistent in studies related to exercise 
interventions to improve CRP levels, many studies have had primarily Caucasian participants 
and/or have used different intensities of aerobic training. Studies evaluating moderate intensity 
exercise generally find either no change in CRP with exercise training or improvement in 
participants that lose weight with exercise. Further, studies which have utilized high intensity 
aerobic exercise have seen consistent reductions in CRP. This may be due to greater mobilization 
of fat (particularly visceral fat) in high intensity exercise compared to moderate. However, little 
data exist directly comparing moderate to high intensity exercise training on CRP levels in obese 
adults; furthermore, no studies, to our knowledge, have evaluated the effect of different exercise 
intensity in African Americans and CRP levels. A study comparing exercise training intensity on 
CRP levels in obese African Americans may find a decrease in CRP levels due to decreased fat 
loss from aerobic exercise training. Thus, aerobic exercise training may represent a potential 
intervention to improve CRP levels in obese African Americans.  
 
 
Chapter III: Methods  
The purpose of the present study was to determine the effects of moderate and high 
intensity aerobic exercise training on CRP in obese African-American men and women. Data for 
the present study was obtained from the High Intensity exercise to Promote Accelerated 
improvements in Cardiorespiratory fitness (HI-PACE) study database (37). Overall, the HI-
PACE study was primarily looking at the change in CRF following the exercise intervention. 
The HI-PACE methodology has been approved by the East Carolina Institutional Review Board. 
Each participant signed a written informed consent prior to study enrollment.  
 
Participants  
Participants were recruited using flyers, website advertisement, and e-mail distributions. 
A sample size of 60 will be recruited for this study. Inclusion criteria includes: African American 
race, 35-65 years of age, classified as obese (30.0-45.0 kg/m2) and sedentary (not exercising  20 
minutes on  3 days/week for the last 3 months). Exclusion criteria included: a diagnosis of type 
2 diabetes (blood glucose value >125 mg/dL), any known cardiovascular diseases, unsafe high 
resting blood pressure (systolic >180 mmHg; diastolic > 100 mmHg), significant medical 
conditions/diseases, life threatening conditions, pregnancy or planning to be pregnant, current 
engagement in dietary or weight loss interventions, and non-adherence to study protocols.  
 
Participant Screening  
Study staff screened participants based on the HI-PACE inclusion/exclusion criteria via 
telephone interview. Next, if the participant is eligible, then an orientation session was scheduled 
with the research coordinator to further discuss study design, procedures, and associated risks 
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and benefits. During the screening visit, participant medical/medication history and screening 
measurements (i.e. resting blood pressure measurements, BMI, and waist circumference) were 
performed for inclusion/exclusion purposes. Additionally, a fasted blood draw was performed 
and sent to a clinical laboratory for lipid, glucose, and insulin analyses, and a comprehensive 
metabolic panel. Physical activity levels were measured using a Fitbit Flex (Fitbit Inc., San 
Francisco, CA) for 7 days.  
 
Participant Assessment: Baseline and Follow Up 
The participants were provided with a written informed consent prior to testing. After 
enrollment, baseline measurements including cardiorespiratory fitness (CRF), BMI, DEXA, and 
waist circumference were assessed prior to beginning the exercise intervention. At the 12-week, 
mid-intervention point, CRF, body weight, and other anthropometric measures were assessed. 
Following the 24-week intervention, these measures were repeated. To determine body mass 
index (BMI, in kg/m2), a Digi Tol calibrated scale (Mettler Toledo, Columbus, OH) was utilized. 
The height was measured with the utilization of a stadiometer. Body composition was measured 
with the utilization of dual energy x-ray absorptiometry (DEXA). Participants laid motionless on 
the DEXA machine until scan is complete. Waist circumference was measured at the natural 
waist (inferior border of the rib cage, superior aspect of the iliac crest) via a Gulick tape measure. 
  
Blood Draw: Pre and Post Intervention 
Participants completed a 12-hour fasted blood draw at the East Carolina Heart Institute. A 
venous blood sample of a total of 21 mL of blood was drawn by the study nurse pre and post 
exercise intervention. Blood samples were sent to a clinical laboratory (LabCorp Inc., 
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Burlington, NC) for a complete analysis of metabolic, lipid, insulin level measures, CRP, and 
blood chemistries. The serum separator tube was sent to LabCorp for measurement of C-reactive 
protein.   
 
Exercise Intervention  
 Participants were randomized to the moderate intensity (MOD-INT; n = 20), high 
intensity (HIGH-INT; n = 20), or non-exercise control group (n = 20) for a 24-week intervention. 
The moderate intensity group participated in aerobic exercise at 50% of their VO2 max, and the 
high intensity group participated in aerobic exercise at 75% of their VO2 max. Participants 
underwent supervised exercise for 3-4 days/week on a treadmill to sustain effective control of 
energy expenditure. Both groups obtained 600 MET-minutes/week, which met the current PA 
guidelines (500-1,000 MET-minutes/week). Due to the participants being sedentary, both groups 
exercised at 200-300 MET-minutes during week 1. Each week, the volume of exercise increased 
by 50 MET-minutes until the 600 MET-minute level was achieved by week 7. MET-minutes 
were calculated utilizing the ACSM equations based on treadmill speed and grade, and 
participant weight.   
 Participant heart rate were recorded every five minutes by research staff with the use of a 
Zephyr Bioharness 3 Monitors (Annapolis, MD) to invigilate prescribed exercise intensities for 
each group. The Zephyr Bioharness 3 Monitor recorded heart rate every second the participant is 
wearing the monitor. To collect the mean heart rate for each session, research staff analyzed the 
heart rate data during exercise time via a sub-session annotation on the Omnisense software38. 
The sub-session of exercise time created is specific to the time and will exclude non-exercise 
heart rate data (e.g. warmup, cool down) from the calculation38.  Through this process, exercise 
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intensities were more accurately calculated due to the continuous second-by-second heart rate 
monitoring as opposed to using five minute intervals38.   
 
Statistical Analysis  
 For the present study, we tabulated a means and standard deviations for continuous 
variables. A one-way ANOVA was conducted to compare continuous variables, and a Spearman 
correlation conducted to compare baseline categorical variables. To measure the change in CRP 
across the intervention groups, an ANOVA was performed with an adjustment for baseline 
values. We used an alpha level of <0.05 for all statistical analyses. A Spearman correlation was 
used to analyze the correlation between baseline variables with CRP. Change scores were 
computed to measure change in CRP across baseline variables (ex: body composition, VO2 
ml/kg/min, total cholesterol, etc.). An independent samples T-Test was used for the analyzation 
of CRP in responders vs. non-responders with equal variances assumed.  Responders were 
accounted for CRP levels <0 mg/dL, while non-responders were accounted for CRP levels >0 
mg/dL. 
 
Chapter IV: Results 
 Baseline characteristics for each treatment group are shown in Table 1. There were 11 
participants in the control group, 10 participants in the moderate intensity exercise group, and 13 
in the high intensity exercise group. There were no significant differences between the 
randomization groups for age, gender, weight, BMI, waist circumference, body fat percentage, 
glucose, insulin, and CRP (p> 0.05). Baseline CRP was significantly associated with weight 
(r=0.458, p=0.006), BMI (r=0.537, p=0.001), fat-mass (r=0.454, p = 0.010), WC (r=0.436, p= 
0.010), estimated METS (r=0.392, p=0.032), and triglycerides (r=0.369, p=0.032). The correlation 
between baselineVO2 max (ml•kg•min) and CRP approached significance (r=-0.299, p=0.086).  
We did not observe significant change in CRP levels among study groups in the MOD or 
the HIT group compared to the CON in obese African-American adults (p=1.00). Further, the 
association between exercisers and change in CRP and fat-mass approached a significant change 
(r=-0.379, p=0.07). The HIGH-INT group had a larger increase in VO2 max (ml•kg•min; L/min) 
(p<0.05) compared to the CON group.  Also, there was a significant relationship between the CON 
group and MOD intensity group in estimated METS (p<0.01). Data for changes in clinical risk 
factors between participants based on change in CRP are shown in Table 2. There were no 
significant changes found in CRP for any clinical risk factors between non-responders and 
responders (p>0.05).  
 
 
Chapter V: Discussion  
 The primary finding of the present study is moderate nor high intensity training reduced C-
reactive protein in obese African Americans. Further, we did not find significant changes in weight 
or WC in 6-months of exercise alone, which is in contrast to previous studies in the literature35,36. 
It is important to emphasize that aerobic exercise training has other health benefits such as 
improvements in cardiorespiratory fitness17–19,32. Therefore, other intervention strategies along 
with exercise may be needed to reduce systemic inflammation in obese African Americans (e.g. 
weight loss, nutritional interventions, pharmacological). This is the first study to our knowledge 
which has evaluated the effect of exercise training (or exercise intensity) on CRP levels, 
specifically in obese African Americans who are at increased risk for cardiovascular disease and 
diabetes.  
 Baseline mean CRP values for the HI-PACE participants reported to be 5.5 mg/L, which 
places this population at high risk for CVD according to the AHA24. The results of this study 
suggest that 6 months of aerobic exercise at moderate or HIGH-INT exercise does not reduce CRP 
levels in obese African Americans. These results are consistent with the overall results of several 
large randomized-controlled trials. In the STRRIDE study, Huffman et al.37 observed that 9-months 
of  low amount-moderate intensity (19.3 km/wk at 40-55% peak VO2), low amount-high intensity 
(19.3 km/wk at 65-80% peak VO2) or high amount-high intensity group (32.2 km/wk at 65-80% 
peak VO2)37 did not alter CRP in response to exercise training37. Similarly the INFLAME36 study 
observed no significant reduction in CRP with aerobic exercise group at moderate-to vigorous-
intensity (60-80% VO2 max) compared to a control group for a 4 month intervention period36. In 
line with these studies, Stewart et al.35 found no significant changes in CRP in response to 6 month 
of moderate intensity exercise training at 4, 8, or 12 kcal/kg/week (KKW).  Based on the data from 
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the above studies and the current study, exercise intensity does not appear to be a major modifier 
for systemic inflammation in obese African Americans at risk for CVD.  
Another theme of the literature is that exercise-related reductions in weight or fat mass may 
be necessary to lower CRP in overweight and obese adults. In the present study, we did not observe 
an association between the change in CRP in exercisers (p>0.05). Risk factors for high levels of 
CRP such as body weight, fat mass, and waist circumference did not significantly change in the 
study, therefore this could account for seeing no change in CRP. For example, we observed a 0.64 
kg change in weight for the MOD-INT group and -0.38 kg change for the HIGH-INT group, 
respectively, and a mean overall change in weight of 0.06 kg in all exercisers. Furthermore, studies 
with evidence showing that weight is associated with change in CRP observed a weight change in 
the exercise groups of about 1-3 kg, which is larger than the present study36,39. Church et al.36 
concluded that exercise training without weight loss is not associated with a change in CRP, 
however, the tertile with largest weight reduction (<-1.3 kg) had significant reductions in CRP 
compared to all groups36. Similarly, Stewart et al.35 found that those who lost <-2.6 kg had a 
significantly lowered CRP after the exercise intervention compared to the lowest tertile. Previous 
literature has reported that Caucasians may lose more weight in response to exercise training 
compared to African Americans40. Also, it has been observed that African American women have 
a significantly lower resting metabolic rate compared to Caucasian women, which may contribute 
to a lower magnitude of weight loss in African American41. The INFLAME (15% African 
American) and DREW (90.4% African American) studies included a mix of races, but a subgroup 
analysis for weight loss across race was not performed35,36 . Thus, it is plausible that since we had 
only African American participants that this may account for the low amount weight loss (and in 
turn lack of response in CRP) in exercisers in the present study.   
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The present study had several strengths. The exercises intervention was supervised 
between controlling the differences in intensities and high adherence in both intensity groups. In 
addition, total exercise volume was equivalent in both the MOD-INT and HIGH-INT groups. A 
weakness of the study would be that the present study is an efficacy-based trial and therefore, 
this does not represent a true real-life exercise in a community-based setting such as an exercise 
training at YMCA or local gym. Another limitation of the sample was the preponderance of 
females. Additionally, we did not control for changes in diet, which may affect inflammatory 
markers as well as fat and weight changes. Also, the results of this study will not be 
generalizable to African Americans with type II diabetes or CVD, where systemic inflammation 
may be higher at baseline.  
In conclusion, we observed that neither moderate or high intensity aerobic decreased 
systemic inflammation levels in obese African Americans. Secondly, CRP was not improved with 
a change in fat-mass in exercisers. Future research could allow for the enrollment of Caucasian 
and African Americans, allowing for a more direct comparison between the two races for the 
intervention variables measured. Also, it could entail an interval training aerobic group, as well as 
a resistance training exercise group to bring forth further comparisons in intervention variables. 
Lastly, future studies may want to combine dietary and exercise to potentially lower CRP to a 






Tables and Figures  
 
Table 1: Baseline Participant Characteristics 
 
Variable Control (n=11) Mod Int. (n=10) High Int. (n=13) 
Age (yrs.) 49656.6 50.76.8 48.49.3 
Female (%), n 72.7, 8 80.0, 8 76.9, 10 
Weight (kg) 89.718.8 99.013.0 100.118.3 
BMI (kg/m2) 32.26.2 35.54.6 35.55.9 
WC (cm) 94.313.4 97.79.3 102.613.1 
Fat Mass (kg) 39.28.9 42.97.2 42.26.4 
VO2 (L/min) 1.90.5 1.90.5 1.90.6 
VO2 (ml/kg/min) 20.95.7 19.25.0 18.84.2 
Est METs 
(kcal/kg/hr) 
8.01.6 7.11.7 7.51.5 
Glucose (mg/dL) 90.78.1 93.48.0 92.09.9 
Insulin (uIU/mL)  11.57.2 14.26.3 16.38.2 
Total Cholesterol 
(mg/dL) 
184.830.0 188.445.7 165.832.0 
HDL (mg/dL) 55.511.0 57.115.0 50.516.1 
LDL (mg/dL) 109.825.5 115.146.8 94.723.5 
Triglycerides (mg/dL) 97.653.1 81.221.4 102.743.0 





Table 2. Change in Intervention Statistics; Mean (CI)  
 
  
Variable Control (n=11) Mod Int. (n=10) High Int. (n=13) 
 △ Weight (kg) 1.55 (-0.93 to 4.02) 0.64 (-1.96 to 3.25) -.38 (-2.39 to 1.62) 
△ BMI (kg/m2) 0.60 (-0.30 to 1.50) 0.25 (-0.65 to 1.16) -0.08 (-0.85 to 0.69) 
△ WC (cm) -0.13 (-2.90 to 2.65) 1.67 (-2.68 to 6.02) -1.17 (-2.98 to 0.64) 
△ Fat Mass (kg) -0.35 (-1.16 to 0.47) -0.01 (-1.63 to 1.61) -0.72 (-2.00 to 0.57) 
△ VO2 (L/min) -0.02 (-0.19 to 0.15) 0.15 (.02 to 0.29) 0.23 (0.10 to 0.35) 
△ VO2 (ml/kg/min) -0.45 (-2.62 to 1.73) 1.41 (-0.47 to 3.28) 2.65 (1.15 to 4.15) 
△ Est METs (kcal/kg/hr) -0.28 (-0.91 to 0.35) 1.65 (0.44 to 2.87) 1.02 (0.36 to 1.70) 
△ Glucose (mg/dL) 1.36 (-2.83 to 5.56) -1.70 (-5.94 to 2.54) -1.85 (-6.83 to 3.14) 
△ Insulin (uIU/mL)  
-1.45 (-3.66 to 0.78) 
 
-5.11 (-9.53 to -0.69) -2.63 (-6.62 to 1.36) 
△ Total Cholesterol 
(mg/dL) 
-9.36 (-23.36 to 4.63) 2.00 (-11.87 to 15.87) 1.08 (-13.48 to 15.63) 
△ HDL (mg/dL) -4.45 (-8.53 to -0.38) -0.30 (-3.90 to 3.30) 1.54 (-2.41 to 5.48) 
△LDL (mg/dL) -7.12 (-16.70 to 2.48) 1.08 (-9.75 to 11.91) 3.37 (-8.14 to 14.88) 
△ Triglycerides (mg/dL) -2.82 (-18.31 to 12.67) 5.90 (-9.37 to 21.17) -13.77 (-27.01 to -0.53) 
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△ Weight (kg) -0.09 0.99 
△ BMI (kg/m2) 0.01 0.40 
△ WC (cm) -0.79 0.56 
△ Fat Mass (kg) -1.55 0.43 
△ VO2 (L/min) 0.17 0.09 
△ VO2 (ml/kg/min) 1.96 0.80 
△ Est METs (kcal/kg/hr) 0.95 0.67 
△ Glucose (mg/dL) -0.07 -1.25 
△ Insulin (uIU/mL) -3.76 -2.43 
△ Total Cholesterol (mg/dL) 3.36 -6.00 
△ HDL (mg/dL) 1.36 -2.55 
△ LDL (mg/dL) 1.13 -1.97 
△ Triglycerides (mg/dL) -0.21 -7.4 
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APPENDIX: IRB APPROVAL 
 
